EOLS Q4 2021 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$353M

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$35M+68.4% YoY

Gross Profit

$19M54.3% margin

Operating Income

-$18M-52.0% margin

Net Income

-$18M-52.4% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+29.9%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$257M

Total Liabilities

$176M

Stockholders' Equity

$82M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$21M	+68.4%
Gross Profit	$19M	$13M	+41.5%
Operating Income	-$18M	-$108M	+83.3%
Net Income	-$18M	-$111M	+83.6%

Revenue Segments

Product

$35M100%